|
2024
|
Invention
|
Gtf2i inhibitors and uses thereof. The present invention refers to a molecule for use in the trea... |
|
|
Invention
|
T-cell receptors. The present invention provides a T-cell receptor (TCR) which binds to an immuno... |
|
|
Invention
|
Genetic modification protocols in immune cells. The present invention relates to a method for gen... |
|
|
Invention
|
Vector. A vector for central nervous system (CNS)-specific expression, wherein the vector compris... |
|
|
Invention
|
Device and method for classifying the grade and/or type of cataracts. The present invention conce... |
|
|
Invention
|
Gene therapy. A product comprising: (a) a vector for liver and/or splenic phagocyte-specific expr... |
|
|
Invention
|
Vector production. An enveloped viral particle producer or packaging cell, wherein the cell is mo... |
|
|
Invention
|
Gene therapy. A polynucleotide comprising a nucleotide sequence encoding methyl-CpG binding-prote... |
|
|
Invention
|
Gene therapy. A product comprising: (a) a hematopoietic stem cell (HSC), a hematopoietic progenit... |
|
|
Invention
|
Vector production.
An enveloped viral particle producer or packaging cell, wherein the cell is g... |
|
|
Invention
|
Gene therapy.
Use of cyclosporin H (CsH) or a derivative thereof for increasing the efficiency o... |
|
|
Invention
|
Lxr antagonists. The present invention relates to novel antagonists of the Liver X Receptors (LXR... |
|
|
Invention
|
T-cell receptors. The present invention provides a T-cell receptor (TCR) which binds to a Human T... |
|
2023
|
Invention
|
Compositions and methods for treating diseases and disorders of the central nervous system.
The ... |
|
|
Invention
|
Inhibitors of dux4 activity and their use in therapy. The present invention refers to a peptide o... |
|
|
Invention
|
Method for analyzing a user's reaction to at least one stimulus. Method (100) for analyzing a use... |
|
|
Invention
|
Cdh17 car. The present invention relates to chimeric antigen receptors (CARs) that target Cadheri... |
|
|
Invention
|
Polynucleotide and vector. A polynucleotide comprising a nucleotide sequence encoding an engineer... |
|
|
Invention
|
3d cell culture methods. The present invention is directed to a method for ex-vivo-engineering of... |
|
|
Invention
|
Testing method for staining in dental restorative materials and related testing system. A testing... |
|
|
Invention
|
Deglycosylation of native glycoproteins expressed on a tumor cell surface. The present invention ... |
|
|
Invention
|
Gene therapy of lysosomal storage disorders. The invention relates to means and methods for gene ... |
|
|
Invention
|
Shade guide device, particularly a translucent one, for the dental direct composite restoration o... |
|
|
Invention
|
Pegylated nanostructures for photoacoustic imaging and photothermal therapy of tumor lesions. A p... |
|
|
Invention
|
Biomaterial coated nanostructures for photoacoustic imaging and photothermal therapy of tumor les... |
|
|
Invention
|
Transgene cassettes and epigenetic silencers for the treatment of disorders. An epigenetic silenc... |
|
|
Invention
|
Transgene cassettes. A polynucleotide comprising at least one miR-124 target sequence, and/or at ... |
|
|
Invention
|
Method for isolating hemogenic endothelial cells. The present invention refers to An in vitro met... |
|
|
Invention
|
Cyclosporin h and uses thereof. Use of cyclosporin H (CsH) or a derivative thereof for: (a) reduc... |
|
|
Invention
|
Gene therapy. An adeno-associated viral (AAV) capsid protein, wherein the capsid protein comprise... |
|
|
Invention
|
Methods for haematopoietic stem cell transplantation. A method for haematopoietic stem and/or pro... |
|
|
Invention
|
Gene therapy. Use of a combination of (a) cyclosporin H (CsH) or a derivative thereof, and (b) a ... |
|
|
Invention
|
Lentiviral vector. A lentiviral vector comprising a nucleotide sequence encoding low density lipo... |
|
|
Invention
|
Gene vector.
A gene vector comprising a miRNA sequence target. |
|
|
Invention
|
Fusion proteins and uses thereof. The present invention refers to: a) at least one peptide recogn... |
|
|
Invention
|
Tcr and peptides.
A T-cell receptor (TCR), which binds to a Wilms tumour 1 protein (WT1) peptide... |
|
|
Invention
|
Endogenous gene regulation to treat neurological disorders and diseases. The invention provides t... |
|
2022
|
Invention
|
Polynucleotides useful for correcting mutations in the rag1 gene.
The present invention relates ... |
|
|
Invention
|
Gene therapy.
Use of one or more inhibitor(s) of senescence for increasing the survival and/or e... |
|
|
Invention
|
Permanent epigenetic gene silencing.
A product comprising two or more artificial transcription r... |
|
|
Invention
|
Targeted disruption of t cell receptor genes using engineered zinc finger protein nucleases.
Dis... |
|
|
Invention
|
Engineered transposase and uses thereof.
The present invention relates to an engineered transpos... |
|
|
Invention
|
Image capturing method.
An image capturing method (100) using an image capturing apparatus (1) t... |
|
|
Invention
|
Compositions for improving the transduction of cells by viral vectors.
A combination of: (a) at ... |
|
|
Invention
|
Epigenetic silencing for treatment of cancer.
An epigenetic silencer factor (ESF) comprising a t... |
|
2021
|
Invention
|
Agents and methods for increasing liver immune response.
An agent that increases the number ofKu... |
|
|
Invention
|
Replacement of rag1 for use in therapy.
The present invention relates to an isolated polynucleot... |
|
|
Invention
|
Device for biological cultures.
A cartridge is adapted to house at least one biological sample t... |
|
|
Invention
|
Non-invasive ventilation system for the pre-hospital management of acute respiratory failure.
A ... |
|
2019
|
Invention
|
Asparagine synthetase inhibitors and uses thereof.
The present invention relates to an inhibitor... |
|
2018
|
G/S
|
Perfume; Perfumery; Cosmetics; Skin and body beauty and care preparations, not for medical purpos... |
|
2014
|
G/S
|
Chemicals for use in industry and science; Chemical substances for preserving foodstuffs. Pharmac... |
|
2007
|
G/S
|
Software for the management of a technical-informative
network among doctors, health care field ... |
